| Biotechnology Industry | Healthcare Sector | Dr. Shiro Akinaga Ph.D. CEO | XDUS Exchange | JP3651120002 ISIN |
| Japan Country | 18 Employees | - Last Dividend | 27 Mar 2014 Last Split | - IPO Date |
NANO MRNA Co.,Ltd., based in Tokyo, Japan, is at the forefront of pharmaceutical research and development, embracing micellar nanoparticles technology to create breakthrough treatments. Founded in 1996 and originally known as NanoCarrier Co., Ltd., the company underwent a name change in June 2023 to better reflect its focus on mRNA-based therapies. NANO MRNA Co.,Ltd. is dedicated to addressing complex medical challenges, with a significant emphasis on tissue generation, vaccines, and cancer treatments, utilizing advanced biotechnological methods.
This pipeline product leverages mRNA technology to foster innovations in tissue regeneration and vaccine development, positioned to make significant impacts in medical treatments and preventive measures.
Engaging siRNA technology, this product is currently in phase I clinical trials, focusing on the treatment of breast cancer. It represents NANO MRNA’s commitment to combating one of the most common cancers affecting women worldwide.
Targeting glioblastoma multiforme, a highly aggressive brain tumor, this antisense oligonucleotide (ASO) therapy is under development, showcasing the company's endeavors to tackle hard-to-treat cancers.
A commercially available product, Complex is an antibacterial ear drop solution designed to treat ear infections, demonstrating NANO MRNA's ability to address everyday health concerns alongside its more groundbreaking research efforts.
Expanding its reach beyond pharmaceuticals, NANO MRNA Co.,Ltd. also supplies raw material for cosmetics, tapping into the extensive applications of nanotechnology for beauty and skincare solutions.
Another innovative service provided by NANO MRNA Co.,Ltd. involves platelet-rich therapy, a cutting-edge treatment designed to accelerate the healing of injured tendons, ligaments, muscles, and joints, showcasing the diverse applications of their research in enhancing human health and recovery.